Insider Transactions in Q2 2022 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
889
-0.25%
|
$12,446
$14.86 P/Share
|
|
Jun 28
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
704
-0.28%
|
$9,856
$14.86 P/Share
|
|
Jun 28
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
598
-0.55%
|
$8,372
$14.86 P/Share
|
|
Jun 28
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
495
-0.45%
|
$6,930
$14.86 P/Share
|
|
Jun 24
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
456
-1.01%
|
$6,840
$15.95 P/Share
|
|
Jun 19
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
955
+0.71%
|
-
|
|
Jun 19
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
497
+0.45%
|
-
|
|
Jun 19
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
899
+0.25%
|
-
|
|
Jun 19
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
733
+0.29%
|
-
|
|
Jun 19
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
418
+0.92%
|
-
|
|
Jun 05
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
419
+0.93%
|
-
|
|
Jun 05
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
735
+0.29%
|
-
|
|
Jun 05
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
901
+0.25%
|
-
|
|
Jun 05
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.46%
|
-
|
|
Jun 05
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
957
+0.72%
|
-
|
|
Jun 01
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+1.68%
|
-
|
|
Jun 01
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
311
+1.53%
|
-
|
|
Jun 01
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+1.87%
|
-
|
|
Jun 01
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
374
+1.55%
|
-
|
|
May 27
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
351
-0.14%
|
$4,914
$14.53 P/Share
|
|
May 27
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
749
-0.21%
|
$10,486
$14.53 P/Share
|
|
May 27
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
174
-0.16%
|
$2,436
$14.53 P/Share
|
|
May 27
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43
-0.1%
|
$602
$14.53 P/Share
|
|
May 22
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+0.78%
|
-
|
|
May 22
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
964
+0.27%
|
-
|
|
May 22
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
533
+0.49%
|
-
|
|
May 22
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
786
+0.31%
|
-
|
|
May 22
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
448
+1.0%
|
-
|
|
May 13
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
125
-0.28%
|
$1,500
$12.32 P/Share
|
|
May 13
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
51
-0.05%
|
$612
$12.32 P/Share
|
|
May 13
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
58
-0.05%
|
$696
$12.32 P/Share
|
|
May 13
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
41
-0.1%
|
$492
$12.32 P/Share
|
|
May 13
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
108
-0.04%
|
$1,296
$12.32 P/Share
|
|
May 13
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
40
-0.12%
|
$480
$12.32 P/Share
|
|
May 13
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
165
-0.05%
|
$1,980
$12.32 P/Share
|
|
May 06
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,730
+38.68%
|
-
|
|
May 06
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,730
+42.75%
|
-
|
|
May 06
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,730
+42.75%
|
-
|
|
May 06
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,730
+45.47%
|
-
|
|
Apr 21
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
325
-0.98%
|
$4,225
$13.94 P/Share
|
|
Apr 21
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
477
-1.14%
|
$6,201
$13.94 P/Share
|
|
Apr 18
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
286
-0.68%
|
$4,862
$17.59 P/Share
|
|
Apr 18
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
13,581
-11.08%
|
$230,877
$17.59 P/Share
|
|
Apr 18
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,325
-7.12%
|
$328,525
$17.59 P/Share
|
|
Apr 18
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
18,530
-12.49%
|
$315,010
$17.59 P/Share
|
|
Apr 18
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,413
-13.24%
|
$279,021
$17.59 P/Share
|
|
Apr 18
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
24,400
-6.34%
|
$414,800
$17.59 P/Share
|
|
Apr 13
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,000
-2.53%
|
$190,000
$19.06 P/Share
|
|
Apr 13
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.47%
|
$10,000
$1.9 P/Share
|
|
Apr 12
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
38,836
+23.86%
|
-
|